Daniel M Levine

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 151(Granted Patents)

Location History:

New York, NY (US) (1992 - 2015)
Englewood, NJ (US) (2020)

Company Filing History:

6 out of 22

The Rogosin Institute

Blue Ribbon Bags, LLC

Years Active: 1992-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10607292 - System for remuneration for lost baggage (2020-03-31),

2. 9023833 - Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds (2015-05-05),

3. 8301504 - Systems and methods for managing orders made via a computer network (2012-10-30),

4. 8015068 - Systems and methods for managing orders made via a computer network (2011-09-06),

5. 5674855 - Methods and compositions useful in prophylaxis and therapy of endotoxin (1997-10-07),

6. 5614507 - Protein and peptide free, neutral lipid and phospholipid containing (1997-03-25),

7. 5587366 - Compositions useful in prophylaxis and therapy of endotoxin related (1996-12-24),

8. 5506218 - Methods useful in endotoxin based therapy (1996-04-09),

9. 5344822 - Methods useful in endotoxin prophylaxis and therapy (1994-09-06),

10. 5128318 - Reconstituted HDL particles and uses thereof (1992-07-07),

Title: Innovations and Contributions of Daniel M. Levine

Introduction

Daniel M. Levine is a notable inventor based in New York, NY, with a significant portfolio of nine patents. His work primarily focuses on medical treatments and systems for managing orders through computer networks. Levine's innovative approaches have the potential to impact both healthcare and e-commerce sectors.

Latest Patents

One of Levine's latest patents is a method for treating sepsis in patients with albumin, cholesterol, and HDL levels above minimum thresholds. This invention involves the intravenous administration of an emulsion containing a phospholipid, a neutral lipid, and a cholate salt, aimed at improving treatment outcomes for patients exhibiting specific serum levels. Another significant patent is related to systems and methods for managing orders made via a computer network. This system allows users to schedule pickups for ordered items, providing a user-friendly interface that includes options for frequency of pickup and real-time availability of items.

Career Highlights

Throughout his career, Levine has worked with reputable organizations, including The Rogosin Institute and Sears Brands, LLC. His contributions in these roles have furthered advancements in both medical and technological fields.

Collaborations

Levine has collaborated with notable professionals such as Thomas S. Parker and Bruce R. Gordon, enhancing the impact of his inventions through teamwork and shared expertise.

Conclusion

Daniel M. Levine's innovative work in treating sepsis and improving order management systems showcases his significant contributions to both healthcare and technology. His patents reflect a commitment to advancing solutions that address critical needs in society.

This text is generated by artificial intelligence and may not be accurate.